Introduction
============

Seizures are common in the newborn baby and most frequently occur as a result of birth asphyxia. Increased morbidity and mortality, brain injury and poor neurodevelopmental outcome have been associated with a higher seizure burden ([@aws257-B42]; [@aws257-B40]; [@aws257-B26]; [@aws257-B69]; [@aws257-B39]; [@aws257-B5]; [@aws257-B72]). Directly addressing neonatal seizures is therefore a priority, but current drugs are largely ineffective and may have serious side effects on the neonatal brain ([@aws257-B54]; [@aws257-B19]; [@aws257-B53]). The molecular and cellular mechanisms underlying birth-asphyxia seizures are unknown, but it is obvious that information on the seizure-triggering mechanisms is of crucial importance in the design of novel therapeutic strategies.

A profound acidosis (blood pH 7.00 or lower) at the time of birth is an essential criterion in the diagnosis of perinatal asphyxia ([@aws257-B49]). However, birth asphyxia seizures do not coincide with the maximal blood acidosis but are typically first observed during the recovery period after a delay that usually ranges in human babies from 2 to 16 h ([@aws257-B66]). A wide range of observations have shown that changes in extra- and intracellular pH exert a strong modulatory effect on brain excitability under normal and pathophysiological conditions, whereby an alkalosis enhances excitability while an acidosis has an opposite effect ([@aws257-B67]; [@aws257-B13]; [@aws257-B33]; [@aws257-B31]; [@aws257-B11]; [@aws257-B18]; [@aws257-B59]). This underscores the crucial role of brain pH regulation in seizure generation ([@aws257-B64], [@aws257-B63]; [@aws257-B81]; [@aws257-B74]).

Using an animal model of birth asphyxia based on 6-day-old rat pups, we recently showed that the post-asphyxia seizure burden was tightly linked to an increase in brain extracellular pH during the recovery from the asphyxia-induced acidosis and its subsequent alkaline overshoot, which reached values that were well above the normal brain pH level ([@aws257-B28]). Several lines of evidence showed that this alkaline shift had a direct, causal role in seizure generation. Moreover, the post-asphyxia alkalosis was dramatically reduced by restoring the CO~2~ levels down to normal in a slow, controlled manner. Accordingly, this 'graded restoration of normocapnia' virtually abolished the seizures, suggesting a novel therapeutic manoeuvre for suppression of birth-asphyxia seizures.

It is not known how post-asphyxia brain alkalosis is caused. In the present study we used two-photon imaging of intracellular pH in neocortical neurons *in vivo*, which revealed an intraneuronal alkalosis after asphyxia, with a time course and sensitivity to graded restoration of normocapnia that were similar to what we described before for extracellular alkalosis ([@aws257-B28]). The post-asphyxia brain alkalosis is generated in the absence of a rise of pH in the trunk and blood. Thus, the rise in both extracellular and intracellular pH recorded in the brain implies a net loss of acid equivalents and is attributable to net extrusion of acid across the blood--brain barrier. This conclusion gained direct support from measurements of the pH gradient across the blood--brain barrier. The post-asphyxia increase in blood--brain barrier acid extrusion was inhibited by systemically administered pharmacological blockers of Na/H exchange, which notably, also abolished post-asphyxia seizures.

Materials and methods
=====================

*In vivo* measurement of intraneuronal pH
-----------------------------------------

Male Sprague-Dawley rat pups, postnatal Day 6--7 (where Day 0 refers to the day of birth) were used. All experiments were approved by the University of Maryland Institutional Animal Care and Use Committee. Animals were anaesthetized during surgery with isoflurane. A small, bloodless craniotomy (3 mm in diameter) was made above parietal cortex. A small tear was made in the dura, and the exposed brain was covered with physiological saline, described in [@aws257-B73]. For *in vivo* imaging, anaesthesia was maintained with 0.7--0.9% isoflurane in air or in special gas mixtures (as described later) applied through a funnel loosely placed on the muzzle. Body temperature was maintained by a heating pad at 35°C throughout the experiments. The pups were first exposed for 60 min to 20% CO~2~ and 9% O~2~ (asphyxia). In one of the two groups, the pups breathed air after asphyxia. In the other group, the experimental asphyxia was followed by an immediate restoration of normoxia, but with a graded re-establishment of normocapnia ([@aws257-B28]), by lowering the CO~2~ levels first from 20 to 10% (with appropriate adjustments of N~2~) for 30 min, then to 5% for a further 30 min and finally to virtually zero or room air (graded restoration of normocapnia).

Acetoxymethyl ester dye solution was prepared by dissolving 50 μg of 2′,7′-bis-(2-carboxyethyl)-5-(and-6-)-carboxyfluorescein (BCECF-AM) in 4 μl of 20% pluronic acid in dimethyl sulphoxide (DMSO, Invitrogen) and diluted (1:8) with physiological saline ([@aws257-B73]). Glass pipettes (2--4 μm tip diameter) were pulled (Sutter P2000) and loaded with dye solution. For bulk loading of cortical neurons, pipettes were gradually advanced to a depth of *∼*500 μm into the parietal cortex under two-photon scanning mode, and the dye solution was pressure injected as described by [@aws257-B1]. After loading, the pipette was withdrawn from the cortex, and the craniotomy was covered with warm agarose and a glass coverslip. Imaging was done using a two-photon laser-scanning microscope (Ultima IV, Prairie Technologies) with a Spectra Physics Mai Tai Deep See Ti-Sapphire mode-locked femto-second laser. Layer 2/3 cells were imaged using a ×20 water-immersion objective lens (LUMPlanFI/IR Olympus 0.95 NA) at a depth of 250--350 µm from the surface of the cortex. Twelve frames per minute were acquired and averaged; data were collected over the course of 4 min, with excitation at 825 nm (F825), and over 1 min at 770 nm (F770) at a higher light intensity to maximize signal-to-noise ratio. Images were acquired using a 570 nm dichroic filter. Averaged frames were analysed using a custom software written in MATLAB. The averaged data collected at 825 nm excitation was divided by the averaged data collected at 770 nm to give the ratiometric intraneuronal pH measurement of one 5 min period (F825/F770).

Calibration of the BCECF signal was done in slice preparation. Sprague-Dawley rat pups were anesthetized with isoflurane and decapitated. Equipment and solutions used to prepare 200-µm thick brain slices were described in [@aws257-B80]. All physiological solutions were equilibrated with carbogen (5% CO~2~, 95% O~2~) and kept at 35°C. BCECF-AM (50 μg) was dissolved in 4 μl of 20% pluronic acid in DMSO and then diluted in physiological solution to a final concentration of 5 µM. Slices were placed into the dye solution and allowed to load for 20 min. A slice was placed under the two-photon microscope and first perfused with physiological solution, followed by high K^+^/nigericin ([@aws257-B17]) solutions with a of pH 7.4, 7.2, 7.0 and 6.8, equilibrated with carbogen. Superficial cells were imaged using the paradigm described earlier. The calibration curve was linear over the pH range tested. Although the linear slope is expected to translate faithfully from the *in vitro* calibration to *in vivo* measurements, this is not necessarily true for absolute pH values. Therefore, the data on intracellular pH have been given as changes from the baseline (see [Fig. 1](#aws257-F1){ref-type="fig"}). Figure 1An intraneuronal alkalosis is triggered after asphyxia and suppressed by graded restoration of normocapnia. The experimental changes in inhaled CO~2~ and O~2~ are schematically shown above the recordings. (**A**) Two-photon *in vivo* measurements of intracellular pH changes (mean ΔpH indicated by black line) in 40 layer 2/3 pyramidal neurons shown in colour from five Day 6--7 rat pups. Inset shows BCECF-loaded neurons. Scale bar = 20 µm. (**B**) Intracellular ΔpH in 41 neurons from five rat pups in the graded restoration of normocapnia paradigm.

pH at the end of the two experimental paradigms was compared using Student\'s two-tailed unpaired *t*-test. Data are presented as mean ± SD.

*In vivo* measurement of body and brain pH and blood--brain barrier potential
-----------------------------------------------------------------------------

In these and subsequent experiments, male Wistar rat pups (Day 6) were used with approval by the National Animal Ethics Committee in Finland. The *in vivo* intracranial pH measurements with H^+^-sensitive microelectrodes were done as described previously ([@aws257-B28]). For simultaneous body pH measurements, small incisions were made in the loose skin of the pup's dorsum. Two 4 cm lengths of polyvinyl chloride tube (outer diameter 0.6 mm, inner diameter 0.2 mm) were prepared as pH-sensitive and reference electrodes and inserted into the incisions. The pH-sensitive body electrodes had the same polyvinyl chloride-gelled membrane and backfilling solutions as the intracranial pH microelectrodes ([@aws257-B76]), with a H^+^-sensitive membrane column length of ∼1 mm. The reference electrode was filled with 0.5% agar in 0.9% NaCl.

Brain extracellular pH and body pH were measured in asphyxic conditions (20% CO~2~, 9% O~2~ for 1 h) and for 2 h afterwards. *N*-methyl-isobutyl-amiloride (MIA; Sigma-Aldrich) was given 2.5 mg/kg bodyweight intraperitoneally 30 min before asphyxia ([@aws257-B35]; [@aws257-B28]). The potential difference across the blood--brain barrier (V~BBB~) was obtained as the difference of the reference electrodes in the brain and the body ([@aws257-B27]; [@aws257-B78]). Values of pH or V~BBB~ in the two experimental paradigms were compared using the Mann-Whitney U-test (two tailed). Data are shown as mean ± SD.

Assessment of blood--brain barrier permeability using sodium fluorescein
------------------------------------------------------------------------

For the asphyxia group, 30 min after termination of asphyxia, 4 ml/kg body weight of 10% sodium fluorescein (Sigma-Aldrich) was injected intraperitoneally ([@aws257-B21]). Thirty minutes after sodium fluorescein administration ([@aws257-B20]), pups were anaesthetized with isoflurane and then perfused with ice-cold 0.9% NaCl through the left ventricle, with a cut in the right auricle for 25 min, a period of time that allows for the outflowing fluid to run clear. Whole brains were dissected out, weighed and frozen in liquid nitrogen, and then kept at −80°C till further processing. For the negative control group (with intact blood--brain barrier), rat pups were removed from the nest and kept at 35°C for 90 min, injected with sodium fluorescein and, 30 min later, processed as described earlier. For the positive control group (with mannitol-induced damage of the blood--brain barrier), rat pups were injected with sodium fluorescein; 30 min later, under isoflurane anaesthesia and on a heating pad set to 35°C, a small thoracotomy was made to expose the tip of the left ventricle. Over a period of 2 min, 30 µl of 24% [d]{.smallcaps}-mannitol (w/w) in 0.9% NaCl ([@aws257-B29]) was infused into the left ventricle. The pups were left under anaesthesia for a further 20 min before being processed, as described earlier.

Brain content of sodium fluorescein was measured as described before ([@aws257-B38]) with some modifications as follows. Brains were homogenized in 2.5 ml of 50% trichloroacetic acid and centrifuged for 15 min at 10 000*g*. The supernatant was diluted with 5 M NaOH, 1:0.8. Fluorometry was performed with a Victor2 (Perkin-Elmer) in plates with black frames and clear wells (IsoPlate 96, Perkin-Elmer).

Brain content of sodium fluorescein was compared between the experimental paradigms using Mann-Whitney U-test (two-tailed). Data are shown as mean ± SD.

Behavioural assessment of seizure burden
----------------------------------------

Seizure burden was quantified during the 2 h post-asphyxia period from video recordings, based on the number of loss of righting reflex in freely moving animals as described before ([@aws257-B28]). MIA was administered intraperitoneally 30 min before the onset of experimental asphyxia ([@aws257-B35]). In some experiments, amiloride (amiloride hydrochloride hydrate; Sigma-Aldrich), the blood--brain barrier-impermeable parent drug of MIA ([@aws257-B70]; [@aws257-B22]; [@aws257-B41]), was administered at an identical concentration. Each incidence of loss of righting reflex was given a score of one. The scores for every pup were added to give the total individual seizure burden. Seizure quantifications based on loss of righting reflex were done in uninstrumented animals. Total seizure burden was compared between the experimental paradigms using the Mann-Whitney U-test (two-tailed). Data are shown as mean ± SD. Control experiments with vehicle alone (1.3 mM acetic acid in 0.9% NaCl, 100 ml) did not have any effect.

Effect of *N*-methyl-isobutyl-amiloride on acid extrusion in cortical pyramidal neurons
---------------------------------------------------------------------------------------

To examine the effects of MIA on acid extrusion in neocortical pyramidal neurons, measurements of intracellular pH based on BCECF were done on acute slices in CO~2~/-buffered and CO~2~/-free HEPES (20 mM) buffered solutions. For further details on methods and data, see [Supplementary material](http://brain.oxfordjournals.org/cgi/content/full/aws257/DC1) and [@aws257-B59].

Results
=======

The intracellular pH of parietal cortex layer 2/3 neurons was measured in Day 6 rat pups using *in vivo* two-photon microscopy and the pH-sensitive dye BCECF (inset in [Fig. 1](#aws257-F1){ref-type="fig"}A). When pups were exposed to asphyxia (20% CO~2~ and 9% O~2~), a conspicuous fall in fluorescence took place that levelled off by the end of the 1-h exposure period. This decrease in fluorescence corresponded to an acidification of 0.30 ± 0.08 pH units below the baseline (*n* = 40 neurons from five pups; [Fig. 1](#aws257-F1){ref-type="fig"}A). During the 2-h post-asphyxia period, intracellular pH not only recovered from acidosis but also showed a slower alkalosis with a plateau level of 0.27 ± 0.12 pH units above baseline pH. Importantly, this is a time point when blood pH has already recovered from the post-asphyxia acidosis and, moreover, blood pH does not become alkaline at any point of time under the present experimental conditions ([@aws257-B28]). Hence, the above data and our previous observations on brain extracellular pH (see also [Fig. 2](#aws257-F2){ref-type="fig"}A) clearly indicate that the post-asphyxia alkalosis is confined to brain tissue. Figure 2Enhanced net acid extrusion across the blood--brain barrier takes place after asphyxia and is suppressed by the Na/H exchange blocker, MIA. (**A**) From *top* to *bottom*: the experimental paradigm; sample recording of extracellular pH changes in the brain (red) and in the body (black); sample recording of trans-blood--brain barrier potential difference (V~BBB~, calculated as *V*~brain~--*V*~body~); mean values ± SD in extracellular brain ΔpH (red triangles) and body ΔpH (black squares) in the asphyxia paradigm from six rats; mean values ± SD of *V*~BBB~. (**B**) Data from experiments on five rats where MIA was injected 30 min before the experimental asphyxia. Note strict dependence of steady-state values of *V*~BBB~ on the pH changes across the blood--brain barrier. (**C**) Blood--brain barrier permeability is not disrupted by experimental birth asphyxia, as indicated with sodium fluorescein (NaF) extravasation into the brain (*n* = 4 rat pups in each paradigm). For further details see text.

We have previously shown that graded restoration of normocapnia brought about by gradually reducing CO~2~ in inhaled air during recovery from asphyxia ([@aws257-B28]) suppresses the post-asphyxia alkalosis of brain extracellular pH, but it is not known how graded restoration of normocapnia affects intracellular pH. Therefore, we exposed rats to asphyxia, which again resulted in a decrease in intracellular pH similar to that described above (0.31 ± 0.08 pH units, *n* = 41 neurons from five pups; [Fig. 1](#aws257-F1){ref-type="fig"}B). Importantly, during graded restoration of normocapnia, intracellular pH gradually recovered but with a marked suppression of the overshoot of intracellular pH (*cf*. [Fig. 1](#aws257-F1){ref-type="fig"}A), which was only ∼0.03 ± 0.10 pH units above baseline at 2-h (*P* \< 0.0001, immediate versus graded restoration of normocapnia) closely resembling the suppressing action of graded restoration of normocapnia on the overshoot of extracellular pH ([@aws257-B28]).

As concluded earlier, the fact that brain extracellular and intracellular pH undergo a post-asphyxia alkalosis indicates that there is a net loss of acid equivalents from both compartments. Thus, the most likely explanation that could account for the parallel increase in extracellular and intracellular pH is an increase in net extrusion of acid equivalents across the blood--brain barrier. We directly tested this idea by simultaneous measurements of brain extracellular pH and body pH ([Fig. 2](#aws257-F2){ref-type="fig"}) using one pH-sensitive electrode plus its reference in the brain parenchyma and a similar pair of electrodes in body subcutaneous tissue ([@aws257-B76]). To manipulate acid transport across the blood--brain barrier ([@aws257-B48]), we used the Na/H exchange blocker, MIA.

The brain extracellular pH changes during and after asphyxia were similar to previous measurements ([@aws257-B28]), with a baseline level of 7.20 ± 0.01, peak acidosis at 6.80 ± 0.05 and plateau alkalosis at 7.57 ± 0.04 (*n* = 6 pups). Body pH during asphyxia decreased from 7.42 ± 0.03 to 7.19 ± 0.03 and recovered with no alkaline overshoot, at any instant of time, to a level that was identical to the pre-exposure baseline (7.42 ± 0.01). The recordings in [Fig. 2](#aws257-F2){ref-type="fig"}A show that the time course of pH changes in response to asphyxia is strikingly different in the two compartments, with the brain extracellular pH changes being larger and faster than those in the body. Unlike brain extracellular pH, body pH does not show a post-asphyxia alkaline overshoot. This observation is in full agreement with the blood acid--base data obtained in our previous study ([@aws257-B28]). A finding of crucial importance here is that the application of MIA completely suppressed the post-asphyxia increase in brain extracellular pH (*P* = 0.004, *n* = 5; [Fig. 2](#aws257-F2){ref-type="fig"}B). Clearly, brain extracellular pH and body pH behave as distinct compartments in response to asphyxia and during the post-asphyxia period.

The only structure that could be responsible for the above pH compartmentalization is the blood--brain barrier. The blood--brain barrier in the Day 6 rats is likely tight enough with regard to ionic movements to maintain such a compartmentalization ([@aws257-B10]), which we found was the case. A trans-blood--brain barrier potential difference ([@aws257-B78]; [@aws257-B77]), which was sensitive to the extracellular pH changes in a manner similar to the mature human brain ([@aws257-B77]), was clearly seen in the electrophysiological recordings ([Fig. 2](#aws257-F2){ref-type="fig"}A). The average peak shift during the asphyxia-induced acidosis was similar in the absence (+4.08 ± 0.24 mV, *n* = 6) and presence (+4.05 ± 0.22 mV, *n* = 5) of MIA (*P* = 0.9). At the end of the 2-h post-asphyxia period, the blood--brain barrier potential shift was −3.08 ± 0.37 mV and 0 ± 0.1 mV in the asphyxia and asphyxia plus MIA-treated groups, respectively (*P* = 0.004; [Fig. 2](#aws257-F2){ref-type="fig"}B), indicating that the steady negative shift in trans-blood--brain barrier potential was abolished in parallel with the extracellular pH overshoot in the presence of MIA.

To gain further information on blood--brain barrier permeability, we used sodium fluorescein as an indicator ([Fig. 2](#aws257-F2){ref-type="fig"}C). No significant difference was found in brain fluorescein extravasation after asphyxia when compared with control (128.1 ± 38.7 and 129.9 ± 33.1 ng sodium fluorescein/mg brain tissue, respectively, *n* = 4, *P* = 0.9). In contrast, when the blood--brain barrier was disrupted by injecting 30 µl of 24% mannitol in saline into the left ventricle, a large increase in sodium fluorescein extravasation was observed (549.8 ± 99.1 ng sodium fluorescein/mg brain tissue, *n* = 5, *P* = 0.02). These data provide further evidence that blood--brain barrier permeability is not altered under the present experimental conditions.

If the increase in brain pH is caused by an enhanced efflux of acid equivalents from the brain across the blood--brain barrier, one might assume that it is large enough to cause a detectable transient in the body pH measurements. Indeed, we found that, during the time window of maximum increase in brain extracellular pH, a small deflection to the acid direction in body pH could be observed in four out of six recordings, including the one shown in [Fig. 2](#aws257-F2){ref-type="fig"}A.

Consistent with a key role of the blood--brain barrier in the functional compartmentalization of the brain pH during and after asphyxia was that, when plotting brain extracellular pH against body pH, a profound hysteresis was observed ([Fig. 3](#aws257-F3){ref-type="fig"}A). Blocking the blood--brain barrier Na/H exchange using the inhibitor MIA completely inhibited the post-asphyxia overshoot alkalosis of brain extracellular pH ([Fig. 2](#aws257-F2){ref-type="fig"}B), which abolished the hysteresis and, under these conditions, brain extracellular pH was related to body pH in an almost linear manner. Thus, the trajectories of body pH and brain extracellular pH in the presence and absence of MIA in [Fig. 3](#aws257-F3){ref-type="fig"}A directly illustrate the role of blood--brain barrier Na/H exchange in dissociating brain extracellular pH regulation from body pH during the post-asphyxia period. MIA had no effect on either body or brain extracellular pH under control conditions during 3.5 h post-injection, which covers the duration of the present experiments (*n* = 3). Figure 3Brain extracellular pH and body pH are functionally compartmentalized in an Na/H exchanger-dependent manner as indicated by the hysteresis in response to experimental asphyxia and by the MIA sensitive seizures. (**A**) The change in brain extracellular pH plotted against the change in body pH. Pups exposed to asphyxia only are shown as blue circles; pups to which MIA was administered are shown as green diamonds. Data taken from [Fig. 2](#aws257-F2){ref-type="fig"}. (**B**) Total seizure burden \[quantified as the number of loss of righting reflex (LRR) per pup\] after asphyxia and asphyxia with administration of MIA or amiloride, at equal doses, from eight rat pups in each paradigm.

In line with the above and previous results ([@aws257-B35]; [@aws257-B28]), we found that MIA reduced seizure burden by 88% (*P* \< 0.0002, *n* = 8; [Fig. 3](#aws257-F3){ref-type="fig"}B). We repeated the behavioural tests with the Na/H exchange inhibitor amiloride, because amiloride penetration across the blood--brain barrier is known to be poor ([@aws257-B70]; [@aws257-B22]; [@aws257-B41]). Notably, the effects of amiloride and MIA were similar ([Fig. 3](#aws257-F3){ref-type="fig"}B), providing further support for the conclusion that activation of Na/H exchange in the blood--brain barrier leads to brain alkalosis and consequent seizures.

All the above evidence points to an action of the blockers of Na/H exchange that is not mediated by changes in neuronal regulation of intracellular pH. Moreover, intracellular pH regulation in hippocampal pyramidal neurons is insensitive to amiloride and its derivatives ([@aws257-B51]) but whether this is true for neocortical neurons is not known ([@aws257-B43]; [@aws257-B47]; [@aws257-B12]). Hence, we examined the effects of MIA on layer 2/3 pyramidal neurons in neocortical slices ([Supplementary material](http://brain.oxfordjournals.org/cgi/content/full/aws257/DC1)). Consistent with previous results on hippocampal pyramidal neurons ([@aws257-B65]; [@aws257-B2]; [@aws257-B4]), acid extrusion following an ammonium prepulse ([@aws257-B7]) was much more efficient (by a factor of ∼10) in the presence of than in the HEPES-buffered solution, indicating a minor role for any -independent acid extruder, such as Na/H exchange ([Supplementary Fig. 1](http://brain.oxfordjournals.org/cgi/content/full/aws257/DC1)). Moreover, application of 10 µM MIA ([@aws257-B75]) did not have any detectable effect on steady-state intracellular pH or acid extrusion either in the presence (*n* = 8 cells) or absence (*n* = 10 cells) of CO~2~/ ([Supplementary material](http://brain.oxfordjournals.org/cgi/content/full/aws257/DC1) and [Supplementary Fig. 1](http://brain.oxfordjournals.org/cgi/content/full/aws257/DC1)). Taken together, these data do not support the view that the actions of MIA and amiloride on brain extracellular pH changes caused by asphyxia are mediated by a block in neuronal Na/H exchange. Here, it is also worth emphasizing that a cell-autonomous increase in neuronal pH caused by acid extrusion during the post-asphyxia period would impose an acid shift in extracellular pH ([@aws257-B67]; [@aws257-B14]; [@aws257-B12]), exactly the opposite of what was seen in our present and previous ([@aws257-B28]) study.

Discussion
==========

The present work shows that post-asphyxia alkalosis in the brain and the consequent seizures are attributable to an enhanced efflux of acid equivalents from the brain that is suppressed by blocking Na/H exchange located in the blood--brain barrier ([@aws257-B48]; [@aws257-B37]). This conclusion is based on (i) the post-asphyxia increase and alkaline overshoot of both brain intracellular pH and extracellular pH, which indicates a net loss of acid equivalents from brain tissue; (ii) direct measurements of the extracellular pH levels and dynamics in the brain and the rest of the body, which indicated a strict compartmentalization of brain extracellular pH by the blood--brain barrier under normal conditions and in response to asphyxia in the Day 6 rats; (iii) the specific block of the post-asphyxia brain alkalosis by MIA, an inhibitor of Na/H exchange ([@aws257-B35]; [@aws257-B48]) and (iv) the equally strong inhibitory action on seizures by MIA and amiloride, whereof the latter is an Na/H exchange inhibitor that has a very low permeability across the blood--brain barrier ([@aws257-B70]; [@aws257-B22]; [@aws257-B41]).

An increase in seizure burden after birth has an incremental, deleterious effect on neurological outcome and therefore it is of utmost importance to identify the mechanisms underlying the pathophysiological post-asphyxia brain alkalosis. It is a well-established fact that a rise in both intracellular and extracellular pH enhances neuronal excitability ([@aws257-B13]; [@aws257-B33]; [@aws257-B31]; [@aws257-B11]; [@aws257-B18]; [@aws257-B59]). The immature brain appears to be particularly sensitive to changes in pH. Recent experiments on neonatal hippocampal slices have shown that a change of 0.05 pH units has a profound effect on endogenous network activity ([@aws257-B59]). A robust cause--effect between brain alkalosis and seizure induction in the immature rat brain was shown in our work on experimental febrile seizures, where tonic--clonic seizures were triggered following an increase in extracellular pH of ∼0.2 pH units induced by hyperthermia-evoked hyperventilation ([@aws257-B64], [@aws257-B63]). Moreover, an intraperitoneal injection of sodium bicarbonate that produced an increase in brain extracellular pH of ∼0.2 pH units triggered seizures in rat pups ([@aws257-B64]).

Consistent with the present results, magnetic resonance spectroscopy following severe human birth asphyxia has shown an abnormally high brain intracellular pH ([@aws257-B56]). A high magnitude and prolonged duration of alkalosis are predictive of poor neurodevelopmental outcome including cerebral atrophy ([@aws257-B57]). The elevated intracellular and extracellular pH in our animal model ([@aws257-B28]) as well as the elevated intracellular pH in the newborn human brain after birth asphyxia ([@aws257-B56]) persist beyond the time of normalization of the post-asphyxia acid--base parameters in the blood ([@aws257-B9]).

We hypothesized that among the acid--base transporters in the blood--brain barrier ([@aws257-B48]), the Na/H exchanger is the most relevant one under our experimental conditions. In full agreement with this idea, we found that MIA abolished the brain-specific post-asphyxia alkalosis and the associated seizures, while having no effects on the changes in body pH or its basal level under control conditions.

It is unlikely that neuronal Na/H exchange contributes to the effects of asphyxia or to the actions of MIA and amiloride seen in the present study. It has been shown that hippocampal neurons are resistant to amiloride and its derivatives ([@aws257-B51]; [@aws257-B12]), and our present findings with MIA indicate that this is also true with regard to neocortical neurons. Furthermore, if the post-asphyxia increase in intracellular pH would be caused by enhanced neuronal Na/H exchange (or by any acid extruder), this would lead to a simultaneous decrease in extracellular pH ([@aws257-B67]; [@aws257-B14]; [@aws257-B12]) while the opposite was observed. Indeed, that an extracellular alkalosis leads to an intracellular alkalosis has been demonstrated in various kinds of mammalian neurons ([@aws257-B58]; [@aws257-B47]; [@aws257-B32]; [@aws257-B55]; [@aws257-B8]). The most parsimonious explanation for the near-parallel increase in intracellular and extracellular pH is that the blood--brain barrier Na/H exchanger-dependent rise in extracellular pH causes a rise in neuronal pH.

Na/H exchange in the blood--brain barrier is prominently sensitive to amiloride and MIA ([@aws257-B44]; [@aws257-B71]; [@aws257-B48]) and a high binding capacity of MIA has been demonstrated in cerebral microvessels ([@aws257-B34]). The endothelial isoforms of Na/H exchangers are located on the luminal side of endothelial cells ([@aws257-B15]; [@aws257-B25]; [@aws257-B52]; [@aws257-B3]), and therefore, they are easily accessible to systemically applied Na/H exchange inhibitors, regardless of the drug permeability across the blood--brain barrier. Amiloride is poorly permeable in the blood--brain barrier ([@aws257-B70]; [@aws257-B22]; [@aws257-B41]), and notably, our present study shows that amiloride is as effective as MIA in abolishing post-asphyxia seizures.

The persistent activation of Na/H exchange in the blood--brain barrier most likely involves a change in the kinetic set point ([@aws257-B58]). This set point renders Na/H exchangers functionally silent at normal intracellular pH and active when intracellular pH becomes acidic ([@aws257-B11]). Notably, an alkaline shift in the set point of intracellular pH occurs when Na/H exchangers are persistently stimulated by hormones and other neuroactive factors ([@aws257-B60]; [@aws257-B46]; [@aws257-B48]). It is well known that various signalling molecules, including hormones, cytokines and growth factors, are released following birth asphyxia and related states ([@aws257-B36]; [@aws257-B79]; [@aws257-B45]; [@aws257-B62]; [@aws257-B68]; [@aws257-B23]; [@aws257-B24]), and an important question for future studies is to identify the factor(s) that act on the Na/H exchanger in the blood--brain barrier.

Interestingly, block of Na/H exchange by MIA administered systemically before hypoxia/ischaemia insult has been shown to have a neuroprotective effect ([@aws257-B35]) that may be at least partly attributable to the drug-induced block of seizures. Another, mutually non-exclusive possibility is that the post-asphyxia recovery of acidosis and the subsequent alkalosis trigger cell damage by activating enzymes, such as proteases and phospholipases ([@aws257-B16]). Analysing the contributions of these mechanisms to neuronal damage following birth asphyxia is an important topic for future studies.

An interesting hypothesis based on the enhanced efflux of acid across the blood--brain barrier is that in human neonates suffering from severe birth asphyxia, the net acid efflux from the brain during the initial alkalosis might cause a slowing down of the early recovery of the systemic acidosis as monitored using blood samples. The total-body volume fraction of the newborn human brain is higher than that of a Day 6 rat, and even in the rat pups, we found evidence that the maximum rate of recovery of brain extracellular pH after asphyxia was paralleled by a small acid transient in body pH ([Fig. 2](#aws257-F2){ref-type="fig"}A). These findings predict that an increase in the severity of birth asphyxia in human newborns is associated with a progressively slower recovery of blood pH that might even include a transient acid shift. This hypothesis can be readily tested in future clinical work.

In conclusion, following neonatal asphyxia, extrusion of acid equivalents across the blood--brain barrier generates a brain alkalosis that promotes seizures. Our results raise the important and worrying question whether resuscitation paradigms where normocapnic conditions established in a fast manner will, in fact, lead to the promotion of birth-asphyxia seizures. Graded restoration of normocapnia and/or drugs targeting the Na/H exchange in the blood--brain barrier offer an effective and straightforward means to functionally suppress seizures and ameliorate other neurological sequela after birth asphyxia ([@aws257-B50]; [@aws257-B6]), and can be readily used in conjunction with other treatment modalities, such as hypothermia ([@aws257-B30]) and optimization of blood oxygenation levels ([@aws257-B61]).
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BCECF

:   2′,7′-bis-(2-carboxyethyl)-5-(and-6-)-carboxyfluorescein

MIA

:   *N*-methyl-isobutyl-amiloride

V~BBB~

:   blood-brain barrier potential
